UY27910A1 - Uso de un derivado de amina cíclica específico o de sus sales farmacéuticamente aceptables para tratar o prevenir la insuficiencia cardiaca - Google Patents

Uso de un derivado de amina cíclica específico o de sus sales farmacéuticamente aceptables para tratar o prevenir la insuficiencia cardiaca

Info

Publication number
UY27910A1
UY27910A1 UY27910A UY27910A UY27910A1 UY 27910 A1 UY27910 A1 UY 27910A1 UY 27910 A UY27910 A UY 27910A UY 27910 A UY27910 A UY 27910A UY 27910 A1 UY27910 A1 UY 27910A1
Authority
UY
Uruguay
Prior art keywords
pharmaceutically acceptable
acceptable salts
amine derivative
cyclic amine
treat
Prior art date
Application number
UY27910A
Other languages
English (en)
Inventor
Dr Brian Guth
Dr Randolph Seidler
Dr Juergen Daemmgen
Original Assignee
Boehringer Ingelheim Pharma
Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29265956&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY27910(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma, Co Kg filed Critical Boehringer Ingelheim Pharma
Publication of UY27910A1 publication Critical patent/UY27910A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención proporciona una composición farmacéutica de un derivado de amina cíclica específico, o sus sales farmacéuticamente aceptables, para tratar o prevenir la insuficiencia cardíaca de cualquier etiología.
UY27910A 2002-07-25 2003-07-31 Uso de un derivado de amina cíclica específico o de sus sales farmacéuticamente aceptables para tratar o prevenir la insuficiencia cardiaca UY27910A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02016602A EP1362590B1 (en) 2002-07-25 2002-07-25 Use of cilobradine or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure

Publications (1)

Publication Number Publication Date
UY27910A1 true UY27910A1 (es) 2004-02-27

Family

ID=29265956

Family Applications (1)

Application Number Title Priority Date Filing Date
UY27910A UY27910A1 (es) 2002-07-25 2003-07-31 Uso de un derivado de amina cíclica específico o de sus sales farmacéuticamente aceptables para tratar o prevenir la insuficiencia cardiaca

Country Status (29)

Country Link
US (1) US20130317008A1 (es)
EP (2) EP1362590B1 (es)
JP (3) JP2005533853A (es)
KR (1) KR20050074432A (es)
CN (1) CN100502874C (es)
AR (1) AR040690A1 (es)
AT (2) ATE257384T1 (es)
AU (1) AU2003254554B8 (es)
BR (1) BR0312852A (es)
CA (1) CA2493208C (es)
CO (1) CO5700723A2 (es)
CY (1) CY1112173T1 (es)
DE (1) DE60200160T2 (es)
DK (2) DK1362590T3 (es)
ES (2) ES2211846T3 (es)
HR (1) HRP20050075B1 (es)
MX (1) MXPA05000617A (es)
MY (1) MY128529A (es)
NZ (1) NZ538424A (es)
PE (1) PE20040706A1 (es)
PL (1) PL214716B1 (es)
PT (2) PT1362590E (es)
SA (1) SA03240350B1 (es)
SI (2) SI1362590T1 (es)
TR (1) TR200400127T4 (es)
TW (1) TWI319321B (es)
UY (1) UY27910A1 (es)
WO (1) WO2004011006A1 (es)
ZA (1) ZA200500084B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60200160T2 (de) * 2002-07-25 2004-11-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von Cilobradine oder pharmazeutisch akzeptablen Salze zur Behandlung oder Prävention von Herzversagen
US20040138306A1 (en) 2002-07-25 2004-07-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
WO2007023775A1 (ja) * 2005-08-23 2007-03-01 Astellas Pharma Inc. 心房細動治療剤
EP1762179A1 (en) 2005-09-07 2007-03-14 Boehringer Ingelheim Vetmedica Gmbh Method for improving diagnostic quality in echocardiography
FR2894825B1 (fr) * 2005-12-21 2010-12-03 Servier Lab Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent
FR2927538B1 (fr) 2008-02-14 2010-02-19 Servier Lab Association d'un inhibiteur du courant if sinusal et d'un beta-bloquant.
FR2961105B1 (fr) * 2010-06-15 2013-02-08 Servier Lab Utilisation de l'association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion de l'angiotensine pour le traitement de l'insuffisance cardiaque
JP2014521714A (ja) * 2011-08-12 2014-08-28 ベーリンガー インゲルハイム フェトメディカ ゲゼルシャフト ミット ベシュレンクテル ハフツング ネコ科動物の心不全を治療および予防する方法において使用するための奇異性電流（Ｉｆ）阻害薬
WO2014122248A1 (en) 2013-02-11 2014-08-14 Boehringer Ingelheim Vetmedica Gmbh Kit-of-parts

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3541811A1 (de) * 1985-11-27 1987-06-04 Thomae Gmbh Dr K Neue cyclische aminderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE3736866A1 (de) * 1987-10-30 1989-05-11 Thomae Gmbh Dr K Mittel zur behandlung des bluthochdrucks und der herzinsuffizienz
DE3805635A1 (de) * 1988-02-24 1989-09-07 Thomae Gmbh Dr K Verwendung von benzimidazolen zur herstellung eines arzneimittels mit antiischaemischen wirkungen am herzen und dessen kombinationen mit ss-blockern oder bradycardica
US5760069A (en) * 1995-02-08 1998-06-02 Boehringer Mannheim Pharmaceuticals Corporation-Smithkline Beecham Corporation Limited Partnership #1 Method of treatment for decreasing mortality resulting from congestive heart failure
JP4240173B2 (ja) * 1998-06-03 2009-03-18 日産化学工業株式会社 インダン誘導体
ATE262518T1 (de) * 1999-06-03 2004-04-15 Yamanouchi Pharma Co Ltd Neuartige isoquinolin-derivate oder salze davon
DE10018401A1 (de) * 2000-04-13 2001-10-25 Boehringer Ingelheim Pharma Verwendung von Bradycardica bei der Behandlung von mit Hypertrophie einhergehenden Myocarderkrankungen und neue Arzneimittelkombinationen
DE60200160T2 (de) * 2002-07-25 2004-11-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von Cilobradine oder pharmazeutisch akzeptablen Salze zur Behandlung oder Prävention von Herzversagen

Also Published As

Publication number Publication date
AU2003254554A1 (en) 2004-02-16
EP1362590A8 (en) 2004-02-25
TR200400127T4 (tr) 2004-02-23
CY1112173T1 (el) 2015-12-09
PL214716B1 (pl) 2013-09-30
AR040690A1 (es) 2005-04-13
HRP20050075A2 (en) 2005-12-31
EP1534296B1 (en) 2011-05-25
EP1534296A1 (en) 2005-06-01
CN100502874C (zh) 2009-06-24
ATE257384T1 (de) 2004-01-15
CN1671392A (zh) 2005-09-21
MY128529A (en) 2007-02-28
JP2013166781A (ja) 2013-08-29
TW200412974A (en) 2004-08-01
SA03240350B1 (ar) 2007-10-29
EP1362590A1 (en) 2003-11-19
CO5700723A2 (es) 2006-11-30
EP1362590B1 (en) 2004-01-07
PT1362590E (pt) 2004-05-31
KR20050074432A (ko) 2005-07-18
NZ538424A (en) 2006-10-27
ES2367109T3 (es) 2011-10-28
WO2004011006A1 (en) 2004-02-05
PE20040706A1 (es) 2004-12-06
SI1534296T1 (sl) 2011-09-30
HRP20050075B1 (hr) 2013-12-20
DE60200160T2 (de) 2004-11-04
JP2005533853A (ja) 2005-11-10
DK1362590T3 (da) 2004-03-29
AU2003254554B8 (en) 2009-02-26
ES2211846T3 (es) 2004-07-16
AU2003254554B2 (en) 2009-01-29
PT1534296E (pt) 2011-08-18
TWI319321B (en) 2010-01-11
DE60200160D1 (de) 2004-02-12
CA2493208A1 (en) 2004-02-05
DK1534296T3 (da) 2011-08-15
MXPA05000617A (es) 2005-08-19
ATE510543T1 (de) 2011-06-15
US20130317008A1 (en) 2013-11-28
CA2493208C (en) 2011-11-01
JP2009256379A (ja) 2009-11-05
BR0312852A (pt) 2005-04-19
ZA200500084B (en) 2005-10-26
SI1362590T1 (en) 2004-04-30
PL372993A1 (en) 2005-08-08

Similar Documents

Publication Publication Date Title
CL2012002526A1 (es) Uso de compuestos inhibidores de dpp iv de formula (i) o (ii) o una de sus sales, para el tratamiento de falla cardiaca.
GT200900283A (es) "terapia de combinación con un compuesto actuando como un inhibidor del receptor adp plaquetario".
NO20074295L (no) Substituerte gamma lactamer som terapeutiske midler
ECSP055853A (es) Nuevos derivados de fluoroglicosidos heterociclicos, productos farmaceuticos que contienen dichos compuestos, y el uso de los mismos
PA8680701A1 (es) Derivados de oxindol
UY27740A1 (es) Nuevos compuestos
ECSP055525A (es) Inhibidores de cinasas de tirosina
AR058163A1 (es) Medicamentos exhaltadores del deseo sexual que comprenden derivados de benzimidazolona
NO20060871L (no) Azepinderivater som farmasoytiske midler
DK1519724T3 (da) Fredericamycin-derivater som lægemidler til behandling af tumorer
BR0315959A (pt) Composto, composição farmacêutica uso do composto, método para o tratamento, método para reduzir a morbidez e a mortalidade associadas com o excesso de peso e processo para a preparação do composto
DK1697371T3 (da) Azabicykliske heterocykliske forbindelser som cannabinoidreceptormodulatorer
CY1112173T1 (el) Η χρηση της cilobradine ή των φαρμακευτικα αποδεκτων αλατων αυτης για την θεραπεια ή την προληψη της καρδιακης ανεπαρκειας
BRPI0617655A2 (pt) composto ou um sal farmaceuticamente aceitável do mesmo, ou um isômero óptico do mesmo, uso de um composto, e, formulação farmacêutica
CL2019000768A1 (es) Compuestos de aza-indazol para usar en lesiones de tendones y/o ligamentos.
CY1110130T1 (el) Παραγωγα μορφολινης για χρηση ως αγωνιστες ντοπαμινης στην θεραπευτικη αγωγη σεξουαλικης δυσλειτουργιας i.α.
AR039633A2 (es) Uso de un compuesto tipo cabergolina para preparar un medicamento para el tratamiento de la fibromialgia y el sindrome de fatiga cronica
DK1578740T3 (da) 1,2,4-triaminobenzenderivater, der er egnede til behandling af lidelser i centralnervesystemet
AR111374A1 (es) Uso de lik066 en pacientes con insuficiencia cardíaca
BRPI0417858A (pt) composto, composição farmacêutica, e, uso de uma composição farmacêutica
AR114270A1 (es) Compuestos de 4-metildihidropirimidinona y su uso farmacéutico
CL2019000727A1 (es) Compuestos de indazol para usar en lesiones de tendones y/o ligamentos.
NO20014855L (no) N-(2-fenyl-4-aminobutyl)-1-naftamider som neurokinin-1- reseptorantagonister
AR062779A1 (es) Tratamiento de la esclerosis multiple (em)
DK1578741T3 (da) Aromatiske forbindelser som anti-inflammatoriske, immunmodulatoriske og anti-proliferative midler

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20150126